Differin $990K Benzene Settlement Your Differin Acne Cleanser May Have Contained a Cancer-Linked Chemical Claim Deadline is May 19

Plaintiffs sued Galderma Laboratories, L.P., the maker of Differin, alleging the company failed to warn consumers that three of its benzoyl peroxide acne products were potentially contaminated with benzene — a chemical classified as a known carcinogen. Galderma denies that the labeling and advertising for its Differin branded acne treatment was misleading, that its products were contaminated with benzene, and denies any wrongdoing or liability. 

Both sides agreed to a $990,000 settlement to end the case. If you bought any of the three covered products in the U.S. between January 1, 2020 and February 19, 2026, you can claim $9 per bottle — no receipt required for up to three products. The claim deadline is May 19, 2026.

Field	Detail
Settlement Amount	$990,000
Claim Deadline	May 19, 2026
Who Qualifies	U.S. purchasers of covered Differin BPO products, Jan. 1, 2020 – Feb. 19, 2026
Payout With Proof	$9.00 per product (no cap on number of products)
Payout Without Proof	$9.00 per product, maximum 3 products ($27 total)
Proof Required	Optional — improves your payout ceiling
Settlement Status	Preliminarily Approved (February 19, 2026)
Administrator	Differin BPO Product Claims Administrator
Official Website	DifferinBPOProductSettlement.com
Phone	1-877-317-7638

Where Things Stand Right Now

• The Differin class action settlement received preliminary approval from the court on February 19, 2026.
• The opt-out and objection deadline is May 19, 2026 — the same day as the claim filing deadline. If you want to preserve your right to sue Galderma separately, you must act before this date.
• The court will determine whether to grant final approval to the Differin class action settlement following a hearing on June 30, 2026. Payments will only go out after final approval is granted and any appeals are resolved.

What Benzene Was Doing in an Acne Wash — and Why That’s a Problem

Benzoyl peroxide (BPO) is one of the most common active ingredients in over-the-counter acne treatments. It kills acne-causing bacteria and helps clear pores. But research has raised concerns that BPO can degrade into benzene — a well-established human carcinogen linked to leukemia and other blood cancers — especially when products are stored at elevated temperatures.

The Differin class action lawsuit alleged that Galderma Laboratories failed to warn consumers that some of its benzoyl peroxide acne treatments, including the Differin Daily Deep Cleanser (5% BPO), Differin Acne Spot Treatment (10% BPO), and Differin Maximum Strength Acne Foaming Cleanser (10% BPO), were potentially contaminated with benzene, a dangerous carcinogen.

The lawsuit claims consumers would not have purchased these products, or would have paid less for them, if they had known about the potential benzene contamination. The core legal theory is consumer deception — not a product recall or proven health injury. Galderma denies all allegations but agreed to settle to avoid the cost and uncertainty of continued litigation.

Three Products Are Covered — and One Very Popular Differin Item Is Not

This is the part most people get wrong. The product Differin is best known for — the adapalene retinoid gel — is not part of this settlement at all. This is strictly about the benzoyl peroxide line.

The three covered products are:

• Differin Daily Deep Cleanser (5% Benzoyl Peroxide)
• Differin Acne Spot Treatment (10% Benzoyl Peroxide)
• Differin Maximum Strength Acne Foaming Cleanser (10% Benzoyl Peroxide)

You may qualify if:

• You purchased one or more of the three products listed above in the United States
• Your purchase happened between January 1, 2020 and February 19, 2026
• You bought the product for personal, family, or household use — no

Relatd article: $425M Google Gmail Privacy Class Action, Did Google Keep Tracking You After You Said Stop?

$9 Per Bottle — More If You Kept Your Receipt, Capped at $27 If You Didn’t

The payout structure is straightforward, but the receipt question matters.

If you have proof of purchase (a receipt, order confirmation, or credit card statement showing the product name and purchase date): You will receive $9.00 for each product, with no limitation on the number of products you can claim. If you bought ten bottles over six years and have documentation, you can claim all ten.

If you have no proof of purchase: You will receive $9.00 for up to a maximum of three products — a maximum of $27.00.

After deducting attorney fees, administration costs, and service awards from the $990,000 fund, the remaining amount will be distributed to claimants. If total approved claims exceed the available fund, payments may be reduced proportionally. This is standard for settlements of this size, so the final per-product amount could shift depending on total claim volume.

How to Claim Your $9 Per Bottle Before May 19, 2026

Step 1 — Go to the official settlement website at DifferinBPOProductSettlement.com

Step 2 — Complete the claim form online, entering your personal details and identifying which covered products you purchased

Step 3 — Select your proof option. Indicate whether you have receipts or purchase documentation. Without proof, your claim covers up to 3 products. With proof, there is no cap.

Step 4 — Upload documentation (if claiming more than 3 products). Acceptable proof includes retail receipts, Amazon or online order confirmations, or credit card or bank statements showing the product name.

Step 5 — Submit your claim online by May 19, 2026, or mail a completed paper form postmarked no later than May 19, 2026, to: Differin BPO Product Claims Administrator, PO Box 4100, Portland, OR 97208-4100

Step 6 — Save your confirmation. Record your claim confirmation number or save the confirmation email for your records.

You can also call 1-877-317-7638 with questions or to request a paper claim form.

Estimated time to complete: 5 minutes without proof; 10 minutes if uploading documentation.

The Full Timeline: From Lawsuit to Payday

Milestone	Date
Settlement Class Period Begins	January 1, 2020
Settlement Class Period Ends	February 19, 2026
Preliminary Approval Granted	February 19, 2026
Court Notice Issued	March 20, 2026
Claim Filing Deadline	May 19, 2026
Opt-Out Deadline	May 19, 2026
Objection Deadline	May 19, 2026
Final Approval Hearing	June 30, 2026
Expected Payment Date	TBD — after final approval and resolution of any appeals

Frequently Asked Questions

Is the popular Differin adapalene gel covered by this settlement? 

No. The product Differin is best known for — the adapalene retinoid gel — is not part of this settlement at all. The settlement covers only the three benzoyl peroxide products: the Daily Deep Cleanser (5% BPO), Acne Spot Treatment (10% BPO), and Maximum Strength Acne Foaming Cleanser (10% BPO).

Do I need a doctor’s note or proof of health harm to file?

 No. This settlement compensates consumers for purchasing a product they allegedly would not have bought — or would have paid less for — had they known about the potential benzene contamination. You do not need to show any medical injury to receive a payment.

What if I don’t have a receipt?

 You can still file without any proof of purchase and receive $9.00 per product for up to three products — a maximum of $27.00. Only shoppers claiming more than three products need documentation.

Do I need a lawyer to file a claim? 

No. Filing a claim directly at DifferinBPOProductSettlement.com takes about five minutes and requires no legal representation. If you wish to object to the settlement terms or exclude yourself to preserve the right to sue Galderma independently, consulting an attorney before May 19, 2026 is advisable.

Is this settlement legitimate?

 Yes. This is a proposed class action settlement reached in the U.S. District Court for the Northern District of Illinois against Galderma Laboratories, L.P. The official notice was issued by the court on March 20, 2026. The only authorized settlement website is DifferinBPOProductSettlement.com.

When will I receive my payment? 

Payments will be issued after the court grants final approval and any appeals are resolved. The final approval hearing is June 30, 2026. Realistically, payments are unlikely before late 2026 or early 2027 if the approval is challenged on appeal.

Will this settlement payment affect my taxes? 

Possibly. Small cash payments from consumer product settlements are sometimes considered taxable income. The administrator will issue tax forms where legally required. Consult a tax professional for guidance specific to your situation.

What if I miss the May 19, 2026 deadline?

 If you do nothing and miss the deadline, you remain in the settlement class, give up your right to sue Galderma separately over these claims, and receive no money. There is no indication the court will extend this deadline, so file early.

Sources & References

• Official Settlement Website: DifferinBPOProductSettlement.com
• Official Court Notice (PR Newswire / U.S. District Court, Northern District of Illinois): March 20, 2026 Notice
• Case: Williams v. Galderma Laboratories, L.P., U.S. District Court for the Northern District of Illinois — docket searchable at PACER.gov
• Settlement Administrator Contact: Differin BPO Product Claims Administrator, PO Box 4100, Portland, OR 97208-4100 | 1-877-317-7638

Last Updated: March 31, 2026

Disclaimer: This article is for informational purposes only and does not constitute legal advice. Legal claims and outcomes depend on specific facts and applicable law. For advice regarding a particular situation, consult a qualified attorney.